Zydus Lifesciences has announced a meeting of its Board of Directors scheduled for November 6, 2025. The primary agenda is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2025 (Q2). The company also informed that the trading window, which was closed, will reopen on November 10, 2025.
Board Meeting Announcement
A meeting of the Board of Directors of Zydus Lifesciences Limited is scheduled to be held on November 6, 2025. This meeting will address key company matters and requires attention from stakeholders.
Financial Results on the Agenda
The primary focus of the board meeting is the review and approval of the unaudited financial results for the quarter and half-year ending September 30, 2025 (Q2). These results will provide insights into the company’s performance over the period.
Trading Window Update
Zydus Lifesciences also notified that the trading window, which had been closed in accordance with regulations, will reopen for trading on November 10, 2025. This information is relevant for all Directors and Designated Persons of the Company.
Source: BSE
